Document Detail


Acute effects of lamotrigine (BW430C) in persons with epilepsy.
MedLine Citation:
PMID:  3698937     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sixteen epileptic patients took single doses of lamotrigine, 120 mg or 240 mg. Six photosensitive patients showed reduction (with abolition in two) in photosensitivity after lamotrigine administration. Five subjects with frequent interictal spikes showed reduction in spike frequency over 24 h after lamotrigine administration. The half-life (t1/2) of lamotrigine in subjects taking sodium valproate was prolonged, whereas the t1/2 in subjects taking carbamazepine and/or phenytoin was reduced. The area under the curve of co-medication plasma levels was not affected by a single dose of lamotrigine. Five patients reported mild and generally transitory side effects; some of which represented exacerbation of preexisting complaints.
Authors:
C D Binnie; W van Emde Boas; D G Kasteleijn-Nolste-Trenite; R A de Korte; J W Meijer; H Meinardi; A A Miller; J Overweg; A W Peck; A van Wieringen
Related Documents :
2113207 - Effectiveness of sodium valproate in the treatment of sydenham's chorea.
16962577 - The proconvulsant effects of the gabaa alpha5 subtype-selective compound ry-080 may not...
414807 - The actions of diazepam and phenytoin on a low dose penicillin epileptiform focus in th...
14705847 - Status epilepticus from an illegally imported chinese rodenticide: "tetramine".
11941157 - A comparison between etomidate and methohexital for anesthesia in ect.
18771337 - The effect of acute fenitrothion exposure on a variety of physiological indices, includ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Epilepsia     Volume:  27     ISSN:  0013-9580     ISO Abbreviation:  Epilepsia     Publication Date:    1986 May-Jun
Date Detail:
Created Date:  1986-06-24     Completed Date:  1986-06-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2983306R     Medline TA:  Epilepsia     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  248-54     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Epilepsy / drug therapy*
Female
Half-Life
Humans
Male
Metabolic Clearance Rate
Middle Aged
Photosensitivity Disorders / chemically induced
Triazines / adverse effects*,  metabolism,  therapeutic use
Chemical
Reg. No./Substance:
0/Triazines; 84057-84-1/lamotrigine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The difficult-to-employ in epilepsy rehabilitation: predictions of response to an intensive interven...
Next Document:  Purine seizure disorders.